Neurovascular and neuroimmune aspects in the pathophysiology of rosacea

Journal of Investigative Dermatology Symposium Proceedings

Volumn 15, Issue 1, 2011, Pages 53-62

  Schwab, Verena D ^a   Sulk, Mathias ^a   Seeliger, Stephan ^b   Nowak, Pawel ^a   Aubert, Jerome ^c   Mess, Christian ^a   Rivier, Michel ^c   Carlavan, Isabelle ^c   Rossio, Patricia ^c   Metze, Dieter ^a   Buddenkotte, Jörg ^a   Cevikbas, Ferda ^d   Voegel, Johannes J ^c   Steinhoff, Martin ^a,d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Galderma R and D   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHEMA; FIBROBLAST; FIBROSIS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS; LYMPH VESSEL; MAST CELL; MORPHOLOGY; MORPHOMETRICS; NERVOUS SYSTEM; NEUROIMMUNOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; ROSACEA; UPREGULATION; VASODILATATION;

EID: 80955137973     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/jidsymp.2011.6     Document Type: Conference Paper

References (49)

1. Amalinei C, Caruntu ID, Giuşca SE et al. (2010) Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 51:215-28
2. Amerini S, Ziche M, Greiner ST et al. (2004) Effects of substance P on mesenteric lymphatic contractility in the rat. Lymphat Res Biol 2:2-10 (Pubitemid 39206641)
3. Arck PC, Slominski A, Theoharides TC et al. (2006) Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126:1697-704 (Pubitemid 44086503)
4. Aroni K, Tsagroni E, Kavantzas N et al. (2008) A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 300:125-31
5. Aroni K, Tsagroni E, Lazaris AC et al. (2004) Rosacea: a clinicopathological approach. Dermatology 209:177-82 (Pubitemid 39370324)
6. Cevikbas F, Steinhoff A, Homey B et al. (2007) Neuroimmune interactions in allergic skin diseases. Curr Opin Allergy Clin Immunol 7:365-73 (Pubitemid 47415278)
7. Collins AB, Colvin RB, Nousari HC et al. (2002) Immunofluorescence methods for diagnosis of renal and skin diseases. In: Manual of Clinical Laboratory Immunology (Rose NR, Hamilton RG, Detrick B, eds) 6th ed, Washington, DC: American Society of Microbiology Press, 393-402
8. Crawford G, Pelle M, James W (2004) Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327-41 (Pubitemid 39178655)
9. Gomaa AH, Yaar M, Eyada MM et al. (2007) Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 34:748-53 (Pubitemid 47459684)
10. Gruber BL (2003) Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 5:147-53
11. Gu Y, Lee HM, Sorsa T et al. (2010) Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunol Med Microbiol 58:218-25.
12. [Published erratum appears in FEMS Immunol Med Microbiol 2010;59(1):117]
13. Guarrera M, Parodi A, Cipriani C et al. (1982) Flushing in rosacea: a possible mechanism. Arch Dermatol Res 272:311-6 (Pubitemid 12113031)
14. Guzman-Sanchez DA, Ishiuji Y, Patel T et al. (2007) Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 57:800-5 (Pubitemid 47553073)
15. Hosaka K, Rayner SE, von der Weid PY et al. (2006) Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs. Am J Physiol Heart Circ Physiol 290:H813-22
16. Huggenberger R, Ullmann S, Proulx ST et al. (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. Exp Med 207:2255-69
17. Ikoma A, Steinhoff M, Ständer S et al. (2006) The neurobiology of itch. Nat Rev Neurosci 7:535-47 (Pubitemid 43995431)
18. Jackson DG (2009) Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev 230:216-31
19. Jansen T, Plewig G (1997) Rosacea: classification and treatment. J R Soc Med 90:144-50 (Pubitemid 27135946)
20. Kawasaki Y, Xu ZZ, Wang X et al. (2008) Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain. Nat Med 14:331-6 (Pubitemid 351347915)
21. Lacey N, Delaney S, Kavanagh K et al. (2007) Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 157:474-81 (Pubitemid 47256121)
22. Lenti L, Zimmermann A, Kis D et al. (2009) PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs. Brain Res 1283:50-7
23. Lipowsky HH, Sah R, Lescanic A (2011) Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes. Am J Physiol Heart Circ Physiol 300:H415-22
24. Lonne-Rahm S, Nordlind K, Edström DW et al. (2004) Laser treatment of rosacea: a pathoetiological study. Arch Dermatol 140:1345-9 (Pubitemid 39473634)
25. Marks R, Harcourt-Webster JN (1969) Histopathology of rosacea. Arch Dermatol 100:683-91
26. Marks R (1989) Rosacea: hopeless hypotheses, marvellous myths, and dermal disorganization. In: Acne and Related Disorders (Marks R, Plewig G, eds). London: Martin Dunitz, 293-9
27. Metz M, Maurer M (2007) Mast cells-key effector cells in immune responses. Trends Immunol 28:234-41 (Pubitemid 46654869)
28. Monument M, Hart D, Befus A et al. (2010) The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures. Bone Joint Surg Am 92:1468-77
29. Morizane S, Yamasaki K, Kabigting FD et al. (2010) Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J Invest Dermatol 130: 1297-306
30. Nordlind K, Thorslund K, Lonne-Rahm S et al. (2006) Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res 298:99-106 (Pubitemid 44341641)
31. Oliveira MC, Pelegrini-da-Silva A, Parada CA et al. (2007) 5-HT acts on nociceptive primary afferents through an indirect mechanism to induce hyperalgesia in the subcutaneous tissue. Neuroscience 145:708-14 (Pubitemid 46357522)
32. Peters EM, Ericson ME, Hosoi J et al. (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 126:1937-47
33. Powell F, Corbally N, Powell D (1993) Substance P and rosacea. J Am Acad Dermatol 28:132-3
34. Powell FC (2005) Clinical practice. Rosacea. N Engl J Med 352:793-803
35. Rattenholl A, Seeliger S, Buddenkotte J et al. (2007) Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis. J Invest Dermatol 127:2245-52 (Pubitemid 47258489)
36. Reich A, Wójcik-Maciejewicz A, Slominski AT (2010) Stress and the skin. G Ital Dermatol Venereol 145:213-9
37. Roosterman D, Goerge T, Schneider SW et al. (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86:1309-79 (Pubitemid 44523706)
38. Seeliger S, Buddenkotte J, Schmidt-Choudhury A et al. (2010) Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol 177:2563-75
39. Sobottka A, Lehmann P (2009) Rosacea 2009: new advances in pathophy-siology, clinical staging and therapeutic strategies. Hautarzt 60: 999-1009
40. Ständer S, Moormann C, Schumacher M et al. (2004) Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 13:129-39 (Pubitemid 38380276)
41. Steinhoff M, McGregor GP, Radleff-Schlimme A et al. (1999) Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 80:49-55 (Pubitemid 29150342)
42. Steinhoff M, Buddenkotte J, Aubert J et al. (2011) Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 15:2-11
43. Steinhoff M, Ständer S, Seeliger S et al. (2003) Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139:1479-88 (Pubitemid 37433137)
44. Steinhoff M, Vergnolle N, Young SH et al. (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6:151-8 (Pubitemid 30082358)
45. Whitfeld M, Gunasingam N, Leow LJ et al. (2011) Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol 64:49-52
46. Wilkin J, Dahl M, Detmar M et al. (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 46:584-7
47. Wollina U (1999) The response of erythematous rosacea to ondansetron. Br J Dermatol 140:561-2
48. Yamasaki K, Di Nardo A, Bardan A et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975-80 (Pubitemid 47222043)
49. Yamasaki K, Kanada K, Macleod DT et al. (2011) TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 131:688-97